Expansion of ST2-expressing macrophages in a patient with bronchiolitis obliterans syndrome

This case study of a patient with BOS after HSCT found increased ST2(+)CD64(+) macrophages in BALF, a potential therapeutic target for treatment-refractory BOS, and reduced CCR2(+)CD14(+) monocytes compared to other lung disorders https://bit.ly/406Uyy9

Detalles Bibliográficos
Autores principales: Yanagihara, Toyoshi, Hata, Kentaro, Suzuki, Kunihiro, Matsubara, Keisuke, Kunimura, Kazufumi, Tsubouchi, Kazuya, Eto, Daisuke, Ando, Hiroyuki, Uehara, Maki, Ikegame, Satoshi, Fukui, Yoshinori, Okamoto, Isamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Research Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227635/
https://www.ncbi.nlm.nih.gov/pubmed/37260458
http://dx.doi.org/10.1183/23120541.00033-2023
Descripción
Sumario:This case study of a patient with BOS after HSCT found increased ST2(+)CD64(+) macrophages in BALF, a potential therapeutic target for treatment-refractory BOS, and reduced CCR2(+)CD14(+) monocytes compared to other lung disorders https://bit.ly/406Uyy9

Ejemplares similares